Characteristics of antibiotic sensitivity of Acinetobacter baumannii bv. tryptophandestruens and Acinetobacter baumannii clinical isolates

Cover Page

Cite item

Full Text

Abstract

The aim of the study was to determine the sensitivity of the bacteria of the biovar Acinetobacter baumannii bv. tryptophandestruens to antibiotics used to treat Acinetobacter-infection. The object of the study was 86 primary clinical isolates of A. baumannii, of which 34 strains of A. baumannii bv. tryptophandestruens isolated in the microbiological laboratory of the Military Medical Academy in 2021–2022. Species identification of bacteria was carried out by MALDI-ToF mass spectrometry. The biovar tryptophandestruens of A. baumannii was determined on a dense chromogenic medium. The sensitivity of A. baumannii isolates to antibiotics was determined by a “Vitek 2 compact” microbiological analyzer (bioMerieux, France). Clinical categories of isolates sensitivity to antibiotics (S) were identified based on the boundary values of minimum suppressive concentrations (MSC, mg/L) established by the European Committee for the Determination of Sensitivity to Antimicrobial Preparates (EUCAST), version 11.0. Isolates of A. baumannii bv. tryptophandestruens and groups of isolates of other A. baumannii very rarely sensitive to meropenem (8.8±4.6%; 3.8±2.6%, respectively, p > 0.05), ciprofloxacin (5.8±4.0; 9.6±4.1%, p > 0.05). Strains sensitive to gentamicin are rarely represented in both groups (26.7±7.55; 19.3±5.5%, p > 0.05) trimethoprim/sulfamethoxazole (38.8±8.3%; 23.6±5.3%, p > 0.05). Sensitivity to polymyxin B was preserved in all strains of both groups (100%). Strains of the tryptophandestruens biovar A. baumannii group surpass strains of the other strain of A. baumannii group in the frequency of isolates with MSC50% tigecycline (MSC50% — 0.5 mg/l; MSC50% — 2 mg/l, respectively), and also have significantly more strains with MSC 0.5 mg/l (52.9% and 15.4%, respectively, p < 0.01 ). Thus, the clinical isolates of the biovar A. baumannii bv. tryptophandestruens have no significant differences with isolates of other strains of A. baumannii in the frequency of strains sensitive (S) to meropenem, ciprofloxacin, gentamicin, trimethoprim/sulfamethoxazole, polymyxin B, but they differ in terms of sensitivity to tigecycline — a higher frequency of strains with an MSC of 0.5 mg/l (p < 0.01) and an MSC of 50%.

About the authors

E. P. Sivolodskii

Military Medical Academy named after S.M. Kirov; St. Petersburg Pasteur Institute

Email: lykraeva@yandex.ru

DSc (Medicine), Professor of the Department of Microbiology, Senior Researcher, Laboratory of Molecular and Biological Technologies

Russian Federation, St. Peterburg; St. Peterburg

L. A. Kraeva

Military Medical Academy named after S.M. Kirov; St. Petersburg Pasteur Institute

Author for correspondence.
Email: lykraeva@yandex.ru

DSc (Medicine), Head of the Laboratory of Medical Bacteriology, Professor of the Department of Microbiology

Russian Federation, St. Petersburg; St. Petersburg

E. V. Melnikova

Military Medical Academy named after S.M. Kirov

Email: lykraeva@yandex.ru

Bacteriologist, Laboratory of Bacteriology of the Central Clinical Diagnostic Laboratory

Russian Federation, St. Peterburg

G. V. Gorelova

Military Medical Academy named after S.M. Kirov

Email: lykraeva@yandex.ru

Head of the Laboratory of Bacteriology, Central Clinical Diagnostic Laboratory

Russian Federation, St. Peterburg

References

  1. Клинические рекомендации. Определение чувствительности микроорганизмов к антимикробным препаратам. Версия 2021-01. Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии. [Clinical guidelines. Susceptibility testing to antimicrobial agents.v. 2021-01. Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC). (In Russ.)] URL: https://www.antibiotic.ru/files/321/clrec-dsma2021.pdf
  2. Патент № 2787267 Российская Федерация. МПК G01N 33/48(2006.01), C12Q1/04(2006.01), СПК G01 33/48(2022.08), C12Q1/04(2022.080, C12Q1/045(2022.08), C12Q2304/00(2022.08). Способ идентификации биовара бактерий Acinetobacter baumannii bv. tryptophandestruens; № 2022109368, заявлено 2022.04.07, опубликовано 2023.01.09 / Сиволодский Е.П. Патентообладатель Сиволодский Евгений Петрович.7 с. [Patent No 2787267 Russian Federation, Int.Cl. G01 33/48(2006.01), C12Q1/04(2006.01), SP.CL.G01N 33/48(2022.08), C12Q1/04(2022.08), C12Q1/04592022.08), C12Q 2304/00(2022.08). Metod of identificccation of biovar bacteria Acinetobacter baumannii bv. tryptophandestruens; No 2023109368, application 2022.04.07.; date of publication 2023.01.09 / Sivolodskij T.P. Proprittors. Sivolodskij Evgenij Petrovich.7 p. (In Russ.)].
  3. Сиволодский Е.П., Краева Л.А., Старкова Д.А., Михайлоов Н.В., Горелова Г.А. Acinetobacter baumannii bv. tryptophandestruens bv. nov., выделенный из клинического материала // Инфекция и иммунитет. 2021. Т. 11, № 5. С. 965–972. [Sivolodskii E.P., Kraeva L.A., Starkova D.A., Mikhailov N.V., Gorelova G.V. Acinetobacter baumannii bv. tryptophandestruens bv. nov., isolated from clinical samples. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2021, vol. 11, no. 5, pp. 965–972. (In Russ.)] doi: 10.15789/2220-7619-ABB-1676

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Sivolodskii E.P., Kraeva L.A., Melnikova E.V., Gorelova G.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).